|
|
|
|
|
by dlnovell
4064 days ago
|
|
I worked for Hospira last year on the Plum A+ and 360 infusion pumps but not the PCA. I'm a little surprised such a blatant security hole wasn't caught, considering the magnitude of the regulatory environment we worked under. I'd never worked in that kind of environment before, and I left shortly after a successfully defended audit of our software development and tracking process and systems. (Although how successful is the development and tracking process if a year later this "bug" comes out?) My guess is that because we were beaten over the head day in and day out focusing on "if this software delivers the wrong medication the patient is probably going to die", and "if you make a mistake in the development process and in change tracking we can lose the ability to make these devices" that the idea of defending against malicious intent was de-emphasized/overlooked. |
|